Literature DB >> 7806230

Fibulin-2 (FBLN2): human cDNA sequence, mRNA expression, and mapping of the gene on human and mouse chromosomes.

R Z Zhang1, T C Pan, Z Y Zhang, M G Mattei, R Timpl, M L Chu.   

Abstract

Fibulin-2 is a new extracellular matrix protein that we recently identified by characterizing mouse cDNA clones. Fibulin-2 mRNA is prominently expressed in mouse heart tissue and is present in low amounts in other tissues. In this study, we isolated and sequenced a 4.1-kb human fibulin-2 cDNA, which encoded a mature protein of 1157 amino acids preceded by a 27-residue signal sequence. The predicted polypeptide contains three consecutive anaphylatoxin-related segments (domain I) in its central region followed by 10 EGF-like repeats (domain II), 9 of which have a consensus sequence for calcium binding. The 408-residue N-terminal region consists of two separate subdomains, a cysteine-rich segment of 150 residues (Na subdomain) and a cysteine-free segment with a stretch of acidic amino acids (Nb subdomain). The 115-residue C-terminal segment (domain III) is similar to the C variant of fibulin-1. The amino acid sequences of the human and mouse fibulin-2 share approximately 90% identity in domains Na, I, II, and III but only 62% identity in domain Nb. The human cDNA lacks an EGF-like repeat, which is alternatively spliced in the mouse cDNA clones, and a potential cell-binding Arg-Gly-Asp sequence found in the Nb domain of the mouse counterpart. Northern blot analysis of mRNA from various human tissues reveals an abundant 4.5-kb transcript in heart, placenta, and ovary tissue. The expression pattern differs from that of fibulin-1. The fibulin-2 gene was localized by in situ hybridization to the p24-p25 region of human chromosome 3 and to the band D-E of mouse chromosome 6.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806230     DOI: 10.1006/geno.1994.1404

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  7 in total

1.  Identification of differentially regulated secretome components during skeletal myogenesis.

Authors:  C Y X'avia Chan; Olena Masui; Olga Krakovska; Vladimir E Belozerov; Sebastien Voisin; Shaun Ghanny; Jian Chen; Dharsee Moyez; Peihong Zhu; Kenneth R Evans; John C McDermott; K W Michael Siu
Journal:  Mol Cell Proteomics       Date:  2011-02-22       Impact factor: 5.911

2.  Detailed mapping of a congenital heart disease gene in chromosome 3p25.

Authors:  E K Green; M D Priestley; J Waters; C Maliszewska; F Latif; E R Maher
Journal:  J Med Genet       Date:  2000-08       Impact factor: 6.318

3.  Patient-to-patient variability in autologous pericardial matrix scaffolds for cardiac repair.

Authors:  Sonya B Seif-Naraghi; Dinah Horn; Pam A Schup-Magoffin; Michael M Madani; Karen L Christman
Journal:  J Cardiovasc Transl Res       Date:  2011-06-22       Impact factor: 4.132

4.  Fibulin-2 is involved in early extracellular matrix development of the outgrowing mouse mammary epithelium.

Authors:  D Olijnyk; A M Ibrahim; R K Ferrier; T Tsuda; M-L Chu; B A Gusterson; T Stein; J S Morris
Journal:  Cell Mol Life Sci       Date:  2014-02-13       Impact factor: 9.261

5.  Loss of fibulin-2 expression is associated with breast cancer progression.

Authors:  Chun-Hui Yi; David J Smith; William W West; Michael A Hollingsworth
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

6.  Fibulin-2 is dispensable for mouse development and elastic fiber formation.

Authors:  Francois-Xavier Sicot; Takeshi Tsuda; Dessislava Markova; John F Klement; Machiko Arita; Rui-Zhu Zhang; Te-Cheng Pan; Robert P Mecham; David E Birk; Mon-Li Chu
Journal:  Mol Cell Biol       Date:  2007-12-10       Impact factor: 4.272

7.  Cellular Recruitment by Podocyte-Derived Pro-migratory Factors in Assembly of the Human Renal Filter.

Authors:  Albert D Kim; Blue B Lake; Song Chen; Yan Wu; Jinjin Guo; Riana K Parvez; Tracy Tran; Matthew E Thornton; Brendan Grubbs; Jill A McMahon; Kun Zhang; Andrew P McMahon
Journal:  iScience       Date:  2019-09-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.